Allogene Therapeutics ALLO
NASDAQ ALLO
$1.62 -0.01 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Market Capitalization (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) posted Market Capitalization of $718.32 million for Q2 2026, up 188.8% from $248.75 million a year earlier and up 20.3% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Market Capitalization (2018 - 2026) Analysis & Trends

For FY2025, Allogene Therapeutics' Market Capitalization came in at $314.3 million, down 30.5% from FY2024.

  • Annual Market Capitalization has declined for five consecutive years, with a five-year compound annual growth rate of -38.4% (FY2020 to FY2025).
  • In prior years, Allogene Therapeutics' Market Capitalization was $452.01 million in FY2024 (-16.5%), $541.34 million in FY2023 (-40.4%), $908.52 million in FY2022 (-57.3%) and $2.13 billion in FY2021 (-40.0%).
  • The Q2 2026 figure stands as the highest quarterly Market Capitalization since Q1 2024.
  • On a year-over-year basis, Market Capitalization increased in three of the last eight quarters, with growth averaging 9.9%.
  • The strongest year-over-year quarter for Market Capitalization in the past five years was Q2 2026, with growth of 188.8%; the weakest was Q1 2022, with a decline of 73.8%.
  • According to Business Quant data, Market Capitalization for the three prior quarters was $597.35 million (Q1 2026), $314.3 million (Q4 2025) and $276.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Allogene Therapeutics 562.91 Mn 562.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 718.32 Mn
Mar 31, 2026 597.35 Mn
Dec 31, 2025 314.30 Mn
Sep 30, 2025 276.72 Mn
Jun 30, 2025 248.75 Mn
Mar 31, 2025 319.15 Mn
Dec 31, 2024 452.01 Mn
Sep 30, 2024 586.60 Mn
Jun 30, 2024 487.09 Mn
Mar 31, 2024 761.92 Mn
Dec 31, 2023 541.34 Mn
Sep 30, 2023 533.12 Mn
Jun 30, 2023 830.65 Mn
Mar 31, 2023 719.96 Mn
Dec 31, 2022 908.52 Mn
Sep 30, 2022 1.56 Bn
Jun 30, 2022 1.64 Bn
Mar 31, 2022 1.31 Bn
Dec 31, 2021 2.13 Bn
Sep 30, 2021 3.66 Bn
API Access

Allogene Therapeutics Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=ALLO&period=max&api_key=YOUR_API_KEY